The Forgotten Corners of Hong Kong: Digging for Value in a Fragmented MarketGlobal Report·2 hours ago09993+1.82%02121-1.58%
Navigating Headwinds: Hong Kong's Mixed-Cap Equities Caught Between Restructuring and Uneven RecoveryGlobal Report·5 hours ago03323+0.93%01958+8.00%
Hua Medicine: Revenue up 74% and gross margin improved, with net loss narrowing amid strong sales growthQuartr·Aug 20 at 07:15 AM02552+1.17%
Hua Medicine swings to RMB 30.2 million H1 FY26 loss; revenue rises 74% to RMB 378.9 millionPUBT·Aug 20 at 07:13 AM02552+1.17%
Hua Medicine Warns on Profit as Wanka Online Raises HKD 350 Million for AI PushGlobal Report·Aug 19 at 04:43 AM01762+0.48%02552+1.17%
HUA MEDICINE-B Expects Interim Results to Swing to RMB30.2 million LossAASTOCKS News·Aug 6 at 08:26 PM02552+1.17%
Hua Medicine Issues Profit Warning as One-Off Bayer Gain Drops OutTip Ranks·Aug 6 at 05:40 PM02552+1.17%BAYRY+0.85%
Hong Kong Market Wrap: Kaisa's Windfall and Jingrui's Liquidation Highlight Sector ExtremesGlobal Report·Aug 5 at 04:12 AM016380.00%021810.00%
The Revaluation of Hong Kong's Long Tail: From Aggregation Theory to Value Chain ShiftsGlobal Report·Jul 29 at 04:19 AM02057+0.24%03296+2.94%
STOCKS | Hong Kong Biotech Stocks Rise as Duality Biotherapeutics Jumps Over 20%CoinLive·Jun 29 at 04:48 AM02552+1.17%02228+3.12%
DKSH expands partnership with Hua Medicine to support Hong Kong diabetes drug rolloutPUBT·Jun 29 at 12:17 AM02552+1.17%
Hua Medicine Shareholders Approve All AGM Resolutions, Renew Capital MandatesTip Ranks·Jun 25 at 05:14 AM02552+1.17%
